{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:18:51Z","timestamp":1777558731980,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s00520-012-1558-9","type":"journal-article","created":{"date-parts":[[2012,8,7]],"date-time":"2012-08-07T02:07:14Z","timestamp":1344305234000},"page":"565-573","source":"Crossref","is-referenced-by-count":21,"title":["Palonosetron plus single-dose dexamethasone for the prevention of nausea and vomiting in women receiving anthracycline\/cyclophosphamide-containing chemotherapy: meta-analysis of individual patient data examining the effect of age on outcome in two phase III trials"],"prefix":"10.1007","volume":"21","author":[{"given":"Luigi","family":"Celio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erminio","family":"Bonizzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Bajetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Sebastiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tania","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matti S.","family":"Aapro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,8]]},"reference":[{"key":"1558_CR1","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1185\/030079905X46313","volume":"21","author":"M Aapro","year":"2005","unstructured":"Aapro M (2005) Optimising antiemetic therapy: what are the problems and how can they be overcome? Curr Med Res Opin 21:885\u2013897. doi: 10.1185\/030079905x46313","journal-title":"Curr Med Res Opin"},{"key":"1558_CR2","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra0706547","volume":"358","author":"PJ Hesketh","year":"2008","unstructured":"Hesketh PJ (2008) Chemotherapy-induced nausea and vomiting. N Engl J Med 358:2482\u20132494","journal-title":"N Engl J Med"},{"issue":"suppl 5","key":"1558_CR3","doi-asserted-by":"crossref","first-page":"v232","DOI":"10.1093\/annonc\/mdq194","volume":"21","author":"F Roila","year":"2010","unstructured":"Roila F, Herrstedt J, Aapro M et al (2010) Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Ann Oncol 21(suppl 5):v232\u2013v243. doi: 10.1093\/annonc\/mdq194","journal-title":"Ann Oncol"},{"key":"1558_CR4","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1200\/JCO.2010.34.4614","volume":"29","author":"E Basch","year":"2011","unstructured":"Basch E, Prestrud AA, Hesketh PJ et al (2011) Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 29:4189\u20134198. doi: 10.1200\/JCO.2010.34.4614","journal-title":"J Clin Oncol"},{"key":"1558_CR5","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/030089160809400401","volume":"94","author":"L Celio","year":"2008","unstructured":"Celio L, Denaro A, Canova S, Gevorgyan A, Bajetta E (2008) Clinical update on palonosetron in the management of chemotherapy-induced nausea and vomiting. Tumori 94:447\u2013452","journal-title":"Tumori"},{"key":"1558_CR6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1470-2045(08)70313-9","volume":"10","author":"M Saito","year":"2009","unstructured":"Saito M, Aogi K, Sekine I et al (2009) Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomized, comparative phase III trial. Lancet Oncol 10:115\u2013124. doi: 10.1016\/s1470-2045(08)70313-9","journal-title":"Lancet Oncol"},{"key":"1558_CR7","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/sj.bjc.6603048","volume":"94","author":"J Vardy","year":"2006","unstructured":"Vardy J, Chiew KS, Galica J, Pond GR, Tannock IF (2006) Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy. Br J Cancer 94:1011\u20131015. doi: 10.1038\/sj.bjc.6603048","journal-title":"Br J Cancer"},{"issue":"suppl 1","key":"1558_CR8","doi-asserted-by":"crossref","first-page":"s49","DOI":"10.1007\/s00520-010-1036-1","volume":"19","author":"I Olver","year":"2011","unstructured":"Olver I, Molassiotis A, Aapro M, Herrstedt J, Grunberg S, Morrow G (2011) Antiemetic research: future directions. Support Care Cancer 19(suppl 1):s49\u2013s55. doi: 10.1007\/s00520-010-1036-1","journal-title":"Support Care Cancer"},{"key":"1558_CR9","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/annonc\/mdp584","volume":"21","author":"M Aapro","year":"2010","unstructured":"Aapro M, Fabi A, Nol\u00e8 F, Medici M, Steger G, Bachmann C, Roncoroni S, Roila F (2010) Double-blind, randomised, controlled study of the efficacy and tolerability of palonosetron plus dexamethasone for 1 day with or without dexamethasone on days 2 and 3 in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy. Ann Oncol 21:1083\u20131088. doi: 10.1093\/annonc\/mdp584","journal-title":"Ann Oncol"},{"key":"1558_CR10","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s00520-010-0941-7","volume":"19","author":"L Celio","year":"2011","unstructured":"Celio L, Frustaci S, Denaro A et al (2011) Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial. Support Care Cancer 19:1217\u20131225. doi: 10.1007\/s00520-010-0941-7","journal-title":"Support Care Cancer"},{"key":"1558_CR11","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/jjco\/hyh138","volume":"34","author":"S Teramukai","year":"2004","unstructured":"Teramukai S, Matsuyama Y, Mizuno S, Sakamoto J (2004) Individual patient-level and study-level meta-analysis for investigating modifiers of treatment effect. Jpn J Clin Oncol 34:717\u2013721. doi: 10.1093\/jjco\/hyh138","journal-title":"Jpn J Clin Oncol"},{"key":"1558_CR12","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/bjc.1996.503","volume":"74","author":"A Bois du","year":"1996","unstructured":"du Bois A, Vach W, Wechsel U, Holy R, Schaefer W (1996) 5-Hydroxyindoleacetic acid (5-HIAA) and cortisol excretion as predictors of chemotherapy-induced emesis. Br J Cancer 74:1137\u20131140","journal-title":"Br J Cancer"},{"key":"1558_CR13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/bjc.1993.295","volume":"68","author":"TJ Hursti","year":"1993","unstructured":"Hursti TJ, Fredrikson M, Steineck G, Borjeson S, Furst CJ, Peterson C (1993) Endogenous cortisol exerts antiemetic effect similar to that of exogenous corticosteroids. Br J Cancer 68:112\u2013114","journal-title":"Br J Cancer"},{"key":"1558_CR14","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1210\/jc.86.2.545","volume":"86","author":"CW Wilkinson","year":"2001","unstructured":"Wilkinson CW, Petrie EC, Murray SR, Colasurdo EA, Raskind MA, Peskind ER (2001) Human glucocorticoid feedback inhibition is reduced in older individuals: evening study. J Clin Endocrinol Metab 86:545\u2013550. doi: 10.1210\/jc.86.2.545","journal-title":"J Clin Endocrinol Metab"},{"key":"1558_CR15","unstructured":"American Cancer Society. Breast cancer facts and figures 2009\u20132010. www.cancer.org\/acs\/groups\/content\/@nho\/documents\/document\/f861009final90809pdf.pdf Accessed 26 July 2011."},{"key":"1558_CR16","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.critrevonc.2008.12.006","volume":"71","author":"JN Jakobsen","year":"2009","unstructured":"Jakobsen JN, Herrstedt J (2009) Prevention of chemotherapy-induced nausea and vomiting in elderly cancer patients. Crit Rev Oncol Hematol 71:214\u2013221. doi: 10.1016\/j.critrevonc.2008.12.006","journal-title":"Crit Rev Oncol Hematol"},{"key":"1558_CR17","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00520-010-0899-5","volume":"19","author":"DG Warr","year":"2011","unstructured":"Warr DG, Street JC, Carides AD (2011) Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of phase 3 trial of aprepitant in patients receiving adriamycin-cyclophosphamide-based chemotherapy. Support Care Cancer 19:807\u2013813. doi: 10.1007\/s00520-010-0899-5","journal-title":"Support Care Cancer"},{"key":"1558_CR18","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4236\/jct.2012.31012","volume":"3","author":"K Yap","year":"2012","unstructured":"Yap K, Leong C, Chan A (2012) Controlling chemotherapy-induced nausea and vomiting with neurokinin-1 receptor antagonists in patients on AC-based chemotherapy\u2014are we there yet? J Cancer Ther 3:90\u2013102. doi: 10.4236\/jct.2012.31012","journal-title":"J Cancer Ther"},{"key":"1558_CR19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/annonc\/mdq600","volume":"22","author":"P Feyer","year":"2011","unstructured":"Feyer P, Jordan K (2011) Updated and new trends in antiemetic therapy: the continuing need for novel therapies. Ann Oncol 22:30\u201338. doi: 10.1093\/annonc\/mdq600","journal-title":"Ann Oncol"},{"key":"1558_CR20","first-page":"374","volume":"5","author":"CM Booth","year":"2007","unstructured":"Booth CM, Clemons M, Dranitsaris G, Joy A, Joung S, Callaghan W, Trudeau M, Petrella T (2007) Chemotherapy-induced nausea and vomiting in breast cancer patients: a prospective observational study. J Support Oncol 5:374\u2013380","journal-title":"J Support Oncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00520-012-1558-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T15:44:33Z","timestamp":1562082273000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-012-1558-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,8]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["1558"],"URL":"https:\/\/doi.org\/10.1007\/s00520-012-1558-9","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,8]]}}}